Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
1PFE | Milan | EUR | Real-time | |
PFE | TradeGate | EUR | Delayed | |
PFE | Frankfurt | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFEm | Buenos Aires | ARS | Delayed | |
PFIZ34 | B3 | BRL | Delayed | |
PFE | Vienna | EUR | Real-time | |
PFE | Ukraine | UAH | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE_KZTQBD | KASE | USD | Delayed | |
PFE_KZTQKD | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
Pfizer Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 14,879 million compared to USD 18,486 million a year ago. Net income was USD 3,115 million compared to USD 5,543 million a year ago. Basic earnings per share from continuing operations was USD 0.55 compared to USD 0.98 a year ago. Diluted earnings per share from continuing operations was USD 0.55 compared to USD 0.97 a year ago. Basic earnings per share was USD 0.55 compared to USD 0.98 a year ago. Diluted earnings per share was USD 0.55 compared to USD 0.97 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Total Revenue | 14878 | 14249 | 13232 | 12734 |
Gross Profit | 11842 | 1135 | 9927 | 9802 |
Operating Income | 4706 | -7120 | 2954 | 2657 |
Net Income | 3115 | -3369 | -2382 | 2327 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Total Assets | 226501 | 215021 | 220168 | |
Total Liabilities | 128537 | 137213 | 117817 | 120875 |
Total Equity | 92558 | 89288 | 97204 | 99293 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1090 | 5240 | -1208 | |
Cash From Investing Activities | 1732 | -10996 | -25485 | |
Cash From Financing Activities | -4931 | 5442 | 27174 | |
Net Change in Cash | -2137 | -317 | 475 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review